The European Medicines Agency (EMA) said some data on the COVID-19 vaccine produced by Pfizer and BioNTech stolen from its servers leaked online in December.
The EMA is the agency responsible for reviewing and approving vaccines against COVID-19, as well as for evaluating and supervising all new drugs introduced into the EU.
An investigation into the cyber attack on the EMA revealed that “documents related to drugs and vaccines against COVID-19 were illegally accessed” and that this information was leaked on the Internet. Authorities are taking the necessary measures, the EMA said.
The agency also said that the European Medicines Regulatory Network is fully operational and that the incident does not affect the deadlines for the assessment and approval of vaccines for COVID-19.
The stolen data appeared on December 31 on several hacker forums and they include snapshots of emails, Word documents, PDF documents and PowerPoint presentations.
The agency announced in December that it had launched an investigation into the attack.
On the same day, Pfizer and BioNTech issued a joint statement revealing that they had been informed by the European Medicines Agency that the attackers had accessed some documents relating to the Pfizer and BioNTech COVID-19 BNT162b2 vaccine candidate submission submitted to the EMA and which are stored on the agency’s server.
The EMA subsequently said that the investigation revealed that the attackers accessed only a limited number of documents.
Since the beginning of the pandemic, several hacker groups, including state-funded groups, have attacked organizations involved in the research and delivery of vaccines against COVID-19.
*The article has been translated based on the content of Informacija.rs by www.informacija.rs. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!
*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.
*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!